Skip to main content

Advertisement

SpringerLink
Log in

Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kim H, Lee SC, Kwon KY et al (2015) Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol PMID: 26626772

  2. Sanchez-Cano A, Orduna E, Segura F et al (2014) Choroidal thickness and volume in healthy young white adults and the relationships between them and axial length, ammetropy and sex. Am J Ophthalmol 158(3):574–583e1

    Article  PubMed  Google Scholar 

  3. Saeedi O, Pillar A, Jefferys J, Arora K, Friedman D, Quigley H (2014) Change in choroidal thickness and axial length with change in intraocular pressure after trabeculectomy. Br J Ophthalmol 98(7):976–979

    Article  PubMed  Google Scholar 

  4. Dedania VS, Bakri SJ (2015) Sustained elevation of intraocular pressure after intravitreal anti-vegf agents: What is the evidence? Retina 35(5):841–858

    Article  CAS  PubMed  Google Scholar 

  5. Hoang QV, Tsuang AJ, Gelman R et al (2013) Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy. Retina 33(1):179–187

    Article  CAS  PubMed  Google Scholar 

  6. Usui S, Ikuno Y, Akiba M et al (2012) Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci 53(4):2300–2307

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Etimesgut Military Hospital, Ankara, Turkey

    Salih Uzun

  2. Etimesgut Asker Hastanesi Goz Hastaliklari Servisi, 06790, Etimesgut-Ankara, Turkey

    Salih Uzun

  3. Department of Ophthalmology, Eskisehir Military Hospital, Eskisehir, Turkey

    Emre Pehlivan

Authors
  1. Salih Uzun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emre Pehlivan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salih Uzun.

Ethics declarations

Conflict of interest

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uzun, S., Pehlivan, E. Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 254, 1651–1652 (2016). https://doi.org/10.1007/s00417-016-3368-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-016-3368-0

Keywords

Search

Navigation